- Home
- BCDA vs SMX Comparison
BCDA vs SMX Comparison
Compare BCDA & SMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- SMX
- Stock Information
- Founded
- BCDA N/A
- SMX N/A
- Country
- BCDA United States
- SMX Ireland
- Employees
- BCDA N/A
- SMX N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- SMX Industrial Machinery/Components
- Sector
- BCDA Health Care
- SMX Technology
- Exchange
- BCDA Nasdaq
- SMX Nasdaq
- Market Cap
- BCDA 7.9M
- SMX 7.6M
- IPO Year
- BCDA N/A
- SMX N/A
- Fundamental
- Price
- BCDA $1.85
- SMX $0.25
- Analyst Decision
- BCDA Strong Buy
- SMX
- Analyst Count
- BCDA 1
- SMX 0
- Target Price
- BCDA $25.00
- SMX N/A
- AVG Volume (30 Days)
- BCDA 61.9K
- SMX 2.5M
- Earning Date
- BCDA 11-13-2024
- SMX 11-29-2024
- Dividend Yield
- BCDA N/A
- SMX N/A
- EPS Growth
- BCDA N/A
- SMX N/A
- EPS
- BCDA N/A
- SMX 6.43
- Revenue
- BCDA $71,000.00
- SMX N/A
- Revenue This Year
- BCDA $6.92
- SMX N/A
- Revenue Next Year
- BCDA N/A
- SMX N/A
- P/E Ratio
- BCDA N/A
- SMX $0.04
- Revenue Growth
- BCDA N/A
- SMX N/A
- 52 Week Low
- BCDA $1.84
- SMX $0.25
- 52 Week High
- BCDA $12.00
- SMX $102.00
- Technical
- Relative Strength Index (RSI)
- BCDA 29.98
- SMX 21.76
- Support Level
- BCDA $2.21
- SMX $0.25
- Resistance Level
- BCDA $2.47
- SMX $0.30
- Average True Range (ATR)
- BCDA 0.16
- SMX 0.04
- MACD
- BCDA -0.04
- SMX 0.05
- Stochastic Oscillator
- BCDA 1.30
- SMX 1.56
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About SMX SMX (Security Matters) Public Limited Company
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.